$Abeona Therapeutics (ABEO.US)$ NEWS Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants Abeona Therapeutics Inc. announced the pricing of an underwritten offering of common stock and pre-funded warrants, expected to generate approximately $75 million in gross proceeds. The offering includes both new and existing investors, with the funds intended for the resubmission of its BLA, commercialization of its product candidate pz-cel, and ...
Abeona Therapeutics股票讨论
只是
abeona therapeutics®宣布pz-cel获得了有利的Medicare报销决定
Abeona Therapeutics® 公布2024年第二季度财务业绩并结束与美国食品药品管理局的A型会议,以就即将提交的Pz-Cel Bla重新提交达成一致
Abeona Therapeutics第二季度运营收入为-1786.4万美元兑美元IBES 估计 -1460万美元
Abeona Therapeutics 第二季度亏损/26c
Abeona Therapeutics第二季度净额为741万美元
Abeona Therapeutics第二季度现金和投资12300万美元
abeona therapeutics: 当Beacon行使许可Aav204的选择时,将获得预付款,并在实现里程碑时获得额外支付
NEWS
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Abeona Therapeutics Inc. announced the pricing of an underwritten offering of common stock and pre-funded warrants, expected to generate approximately $75 million in gross proceeds. The offering includes both new and existing investors, with the funds intended for the resubmission of its BLA, commercialization of its product candidate pz-cel, and ...
🗓️上周的PDUFAs:
$辉瑞 (PFE.US)$ 🎉已批准于4月26日
⇨ BEQVEZ(fidanacogene elaparvovec-dzkt)
▹ 血友病B
▹ BLA
▹ PDUFA日期:2024年第二季度
$Day One Biopharmaceuticals (DAWN.US)$ :已批准4/23 🎉
⇨ OJEMDA(托吡替尼)
▹ 儿童低级别胶质瘤
▹ 新药申请
▹ PDUFA日期:4/30/24
$ImmunityBio (IBRX.US)$ :已批准 4/22 🎉
⇨ Anktiva + BCG
▹ 膀胱癌
▹ 重新提交了新药许可申请
▹ PDUFA日期:2024年4月23日
$Abeona Therapeutics (ABEO.US)$ :CRL 4/22 🙁
⚠...
暂无评论